Business Context and Reporting Period
This Form 8-K filing by BioRestorative Therapies, Inc. (Delaware) reports on the Annual Meeting of Stockholders held on September 13, 2017. The report details the voting results for director elections and the ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document serves solely to disclose the results of the shareholder vote.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies. The only matters addressed were the election of Class III directors and the ratification of Marcum LLP as the independent auditor.
Key Facts for Investor Verification
- Director Election: Stockholders elected Mark Weinreb and A. Jeffrey Radov as Class III directors.
- Voting Results (Directors): Mark Weinreb received 2,783,638 votes for; A. Jeffrey Radov received 2,779,481 votes for. Both nominees faced 727,471 broker non-votes.
- Auditor Ratification: Stockholders ratified the selection of Marcum LLP with 3,511,607 votes for, 7 against, and 3 abstentions.
- Meeting Date: The Annual Meeting occurred on September 13, 2017.